Skip to content

Efficacy and safety of XEN implant for glaucoma treatment

Efficacy and safety of XEN implant for glaucoma treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060177
Enrollment
Unknown
Registered
2022-05-21
Start date
2022-05-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Group 1:XEN Gel implant
Group 3:penetrating canaloplasty

Sponsors

Qingdao Eye Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Open angle glaucoma in which the intraocular pressure cannot be controlled by medications or the visual impairment progresses under the control of medication.

Exclusion criteria

Exclusion criteria: 1. Scar or glaucoma drainage flap exists in the area where the drainage tube is implanted; 2. Active inflammation (e.g. blepharitis, conjunctivitis, keratitis, uveitis); 3. Active iris neovascularization; 4. Anterior chamber intraocular lens; 5. There is vitreous body in the front chamber; 6. There is silicone oil in the eye.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;filtering bleb;complications;drainage tube position;surgical success rate;number of medications;

Countries

China

Contacts

Public ContactPan Xiaojing
panxjcrystal@163.com+86 18661801623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026